- Filed
- Jun 30, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jun 20, 2025 | 27.66M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $129.33K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.66M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.34M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.67M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.35M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $201.2K |
| Current Assets | Q1 2025 · Dec 31, 2024 | $76.81K |
| Total Assets | Q1 2025 · Mar 31, 2025 | $9.81M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $9.95M |
| Net Income | Q1 2025 · Dec 31, 2024 | −$718.79K |
| Net Income | Q1 2025 · Sep 30, 2024 | −$271.33K |
| Net Income | Q1 2025 · Jun 30, 2024 | −$190.74K |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$160.47K |
| Stockholders Equity | Q1 2025 · Sep 30, 2024 | $9.32M |
| Stockholders Equity | Q1 2025 · Jun 30, 2024 | −$395.75K |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | −$205K |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | −$44.54K |
| Capex | Q1 2025 · Mar 31, 2024 | $41.46K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$164.76K |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $149.28K |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$160.47K |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $2.71K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $10.9K |
| Revenue | Q1 2025 · Mar 31, 2024 | $13.61K |